Menu
GeneBe

GLI1

GLI family zinc finger 1, the group of Zinc fingers C2H2-type

Basic information

Region (hg38): 12:57459784-57472268

Previous symbols: [ "GLI" ]

Links

ENSG00000111087NCBI:2735OMIM:165220HGNC:4317Uniprot:P08151AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • polydactyly of a biphalangeal thumb (Limited), mode of inheritance: AR
  • Ellis-van Creveld syndrome (Supportive), mode of inheritance: AR
  • postaxial polydactyly type A (Supportive), mode of inheritance: AR
  • polydactyly of a biphalangeal thumb (Supportive), mode of inheritance: AD
  • polydactyly, postaxial, type A8 (Limited), mode of inheritance: Unknown

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Polydactyly, postaxial, type A8; Polydactyly, preaxial IARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingMusculoskeletal28973407; 30620395

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GLI1 gene.

  • Inborn genetic diseases (35 variants)
  • not provided (27 variants)
  • Polydactyly, postaxial, type A8 (9 variants)
  • Preaxial hand polydactyly (4 variants)
  • not specified (3 variants)
  • GLI1-related condition (2 variants)
  • Premature ovarian failure (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GLI1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
8
clinvar
5
clinvar
13
missense
41
clinvar
4
clinvar
5
clinvar
50
nonsense
2
clinvar
1
clinvar
3
start loss
0
frameshift
2
clinvar
2
clinvar
4
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
1
1
non coding
1
clinvar
1
Total 2 4 44 12 10

Highest pathogenic variant AF is 0.00000658

Variants in GLI1

This is a list of pathogenic ClinVar variants found in the GLI1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-57464042-C-T GLI1-related disorder Likely benign (May 28, 2019)3043937
12-57464074-C-T not specified Uncertain significance (Jan 04, 2022)2220134
12-57464746-G-A GLI1-related disorder Likely benign (Mar 11, 2019)3058711
12-57464770-G-A GLI1-related disorder Benign/Likely benign (Dec 31, 2019)725547
12-57464793-C-A GLI1-related disorder Likely benign (Dec 31, 2019)790865
12-57464816-C-T Polydactyly, postaxial, type A8 Pathogenic (Jan 03, 2022)561215
12-57464842-C-T GLI1-related disorder Likely benign (Oct 01, 2022)715808
12-57465160-C-G not specified Uncertain significance (May 24, 2023)2551040
12-57465179-C-T not specified Uncertain significance (May 03, 2023)2542076
12-57465181-T-C not specified Uncertain significance (Jul 14, 2021)2405713
12-57465191-A-G not specified Uncertain significance (Sep 20, 2023)3100164
12-57465203-G-A not specified Likely benign (Jan 03, 2024)3100165
12-57465224-C-G GLI1-related disorder Benign (Nov 01, 2023)730133
12-57465251-G-A Malignant tumor of prostate Uncertain significance (-)161547
12-57465255-G-A Uncertain significance (Jun 16, 2022)1810605
12-57465638-A-C not specified Uncertain significance (Mar 17, 2023)2526466
12-57465648-G-A Preaxial hand polydactyly • Polydactyly, postaxial, type A8 • GLI1-related disorder Benign (Aug 10, 2021)1277191
12-57465822-A-G not specified Uncertain significance (Sep 14, 2022)2311849
12-57465836-G-A not specified Uncertain significance (Jul 14, 2021)2216053
12-57465841-G-A Likely benign (Dec 31, 2019)726113
12-57465843-G-A not specified Uncertain significance (Feb 23, 2023)2488455
12-57465876-G-T GLI1-related disorder Uncertain significance (Jan 22, 2024)2633545
12-57466263-C-T GLI1-related disorder Benign (Feb 21, 2019)3056398
12-57466291-T-TG Likely pathogenic (Dec 24, 2021)2440510
12-57466293-G-T Polydactyly, postaxial, type A8 Conflicting classifications of pathogenicity (Feb 10, 2023)2429115

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GLI1protein_codingprotein_codingENST00000228682 1112128
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
7.66e-140.8431256870611257480.000243
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.085806580.8820.00003767095
Missense in Polyphen278318.440.872993457
Synonymous0.9872342540.9210.00001342411
Loss of Function1.942740.30.6700.00000220448

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002150.000214
Ashkenazi Jewish0.0005950.000595
East Asian0.0001670.000163
Finnish0.0001420.000139
European (Non-Finnish)0.0003150.000308
Middle Eastern0.0001670.000163
South Asian0.0002620.000261
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acts as a transcriptional activator (PubMed:19706761, PubMed:10806483, PubMed:19878745, PubMed:24311597, PubMed:24217340). Binds to the DNA consensus sequence 5'- GACCACCCA-3' (PubMed:2105456, PubMed:8378770, PubMed:24217340). May regulate the transcription of specific genes during normal development (PubMed:19706761). May play a role in craniofacial development and digital development, as well as development of the central nervous system and gastrointestinal tract. Mediates SHH signaling (PubMed:19706761). Plays a role in cell proliferation and differentiation via its role in SHH signaling (Probable). {ECO:0000269|PubMed:10806483, ECO:0000269|PubMed:11238441, ECO:0000269|PubMed:19706761, ECO:0000269|PubMed:19878745, ECO:0000269|PubMed:2105456, ECO:0000269|PubMed:24217340, ECO:0000269|PubMed:24311597, ECO:0000269|PubMed:8378770, ECO:0000305}.;
Pathway
Basal cell carcinoma - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Hedgehog signaling pathway - Homo sapiens (human);HH-Core;Dopaminergic Neurogenesis;Hedgehog ,on, state;Hedgehog ,off, state;EDA Signalling in Hair Follicle Development;Tumor suppressor activity of SMARCB1;Hedgehog Signaling Pathway;Hedgehog Signaling Pathway;Signal Transduction;Hedgehog;Hedgehog;Degradation of GLI1 by the proteasome;Hedgehog ,off, state;GLI proteins bind promoters of Hh responsive genes to promote transcription;Hedgehog ,on, state;Signaling by Hedgehog;Hedgehog signaling events mediated by Gli proteins (Consensus)

Recessive Scores

pRec
0.564

Intolerance Scores

loftool
0.786
rvis_EVS
-0.88
rvis_percentile_EVS
10.56

Haploinsufficiency Scores

pHI
0.983
hipred
Y
hipred_score
0.637
ghis
0.568

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.836

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gli1
Phenotype
neoplasm; reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype; cellular phenotype;

Zebrafish Information Network

Gene name
gli1
Affected structure
retinal ganglion cell
Phenotype tag
abnormal
Phenotype quality
misrouted

Gene ontology

Biological process
osteoblast differentiation;smoothened signaling pathway;spermatogenesis;ventral midline development;positive regulation of cell population proliferation;regulation of smoothened signaling pathway;response to wounding;epidermal cell differentiation;dorsal/ventral pattern formation;proximal/distal pattern formation;cerebellar cortex morphogenesis;smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation;pituitary gland development;lung development;prostate gland development;regulation of osteoblast differentiation;positive regulation of DNA replication;positive regulation of smoothened signaling pathway;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;digestive tract morphogenesis;notochord regression;positive regulation of cardiac muscle cell proliferation;canonical Wnt signaling pathway;negative regulation of canonical Wnt signaling pathway;liver regeneration;positive regulation of cell cycle G1/S phase transition;regulation of hepatocyte proliferation
Cellular component
nucleus;nucleoplasm;cytoplasm;cytosol;axoneme;ciliary tip;ciliary base
Molecular function
RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;chromatin binding;protein binding;microtubule binding;transcription regulatory region DNA binding;metal ion binding